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E-mail address: rachael.tarlinton@nottingham.ac.uThe large-scale outbreak of disease across Northern Europe caused by a new orthobunyavirus known as
Schmallenberg virus has caused considerable disruption to lambing and calving. Although advances in
technology and collaboration between veterinary diagnostic and research institutes have enabled rapid
identiﬁcation of the causative agent and the development and deployment of tests, much remains
unknown about this virus and its epidemiology that make predictions of its future impact difﬁcult to
assess. This review outlines current knowledge of the virus, drawing comparisons with related viruses,
then explores possible scenarios of its impact in the near future, and highlights some of the urgent
research questions that need to be addressed to allow the development of appropriate control strategies.
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The ﬁrst record of the town of Schmallenberg in the state of
North Rhine-Westphalia, Germany dates from 1243. Over
700 years later, its name is now linked with the latest vector-borne
viral disease to pose a threat to livestock in Northern Europe. Sch-
mallenberg virus (SBV) was originally identiﬁed in clinical samples
from cattle in Germany presenting with fever and milk drop syn-
drome (with occasional reports and diarrhoea and abortion), that
were submitted for investigation to the Friedrich Loefﬂer Institute
(FLI) in October 2011.
Following elimination of the usual causes of such clinical signs
in cattle, blood samples from three cattle were subjected to the
new technology of deep sequencing known as metagenomic anal-
ysis, which allows the sequencing of all nucleic acid present in a
sample. As is typical with this approach, a large amount of host
genomic and known bacterial sequences were identiﬁed, the latter
most likely as a consequence of prolonged sample storage. How-
ever, present within the samples were genetic sequences from a
novel Bunyavirus of the genus Orthobunyavirus which were most
similar to viruses of the Simbu serogroup including Akabane and
Shamonda virus (Hoffmann et al., 2012). This group of viruses pro-
duce a syndrome in ruminants referred to as arthrogryposis
hydranencephaly syndrome (AHS), resulting in abortions, still-
births and congenital defects in neonatal cattle, sheep and goats
following infection during pregnancy.
Outbreaks of diarrhoea, fever and milk drop syndrome had also
been reported in The Netherlands over the late summer and earlyll rights reserved.
k (R. Tarlinton).autumn of 2011. Retrospective testing of blood samples from these
cases at the Central Veterinary Laboratories, Lelystad demon-
strated SBV RNA in 36% of animals indicating that the same caus-
ative agent was responsible for the disease outbreaks in both
countries (Muskens et al., 2012).
This review describes what is currently known about SBV
(based on published data up to 19th June 2012) compared with
related Bunyaviridae. Our knowledge of this virus is rapidly
expanding as many research groups are actively working in this
area, and the situation changes as the outbreak progresses. Useful
websites that provide the most up-to-date information are listed
in Table 1.
Schmallenberg virus: What is currently known?
Following its initial detection using molecular methods, it was
not clear whether SBV was anything more than an incidental ﬁnd-
ing. However, the teratogenic nature of genetically similar viruses,
and the fact that orthobunyaviruses of the Simbu serogroup had
not previously been reported in Europe, was enough to warrant in-
creased vigilance for malformed ruminant fetuses and neonates
and the development of a primer- and probe-based reverse-
transcriptase quantitative PCR (qRT-PCR) test for the ‘S’ segment
of the virus by the FLI (Hoffmann et al., 2012). These steps proved
prudent, as large numbers of malformed lambs were reported from
the start of the 2011–2012 lambing season in continental Europe.
The ﬁrst clinical report described lambs born in The Netherlands
during November and December 2011 with malformations consis-
tent with the AHS syndrome (van den Brom et al., 2012). Twenty-
two of 54 lambs with such distinct malformations tested positive
by qRT-PCR for SBV RNA (van den Brom et al., 2012).
Table 1
A selection of useful websites providing information on Schmallenberg virus (SBV) infection in Europe.
Website Comment
http://www.ﬂi.bund.de/en/startseite/current-news/animal-disease-
situation/new-orthobunyavirus-detected-in-cattle-in-germany.html
Friedrich Loefﬂer Institute, Germany: current distribution and publications listed
http://agriculture.gouv.fr/maladies-animales,11003 Ministry of Agriculture, France
http://www.izs.it/IZS/Engine/RAServePG.php/P/357410010300/M/
250010010303
Istituto Giuseppe Caporale, Italy
http://www.vwa.nl/onderwerpen/dierziekten/dossier/
schmallenbergvirus
Food and Consumer Product Safety Authority, The Netherlands
http://www.defra.gov.uk/animal-diseases/a-z/schmallenberg-virus Department for the Environment Food and Rural Affairs (DEFRA) provides ofﬁcial statements
on current UK status of SBV
http://www.defra.gov.uk/ahvla/tag/Schmallenberg/ Animal Health and Veterinary Laboratories Agency (AHVLA) lists UK outbreaks of SBV
chronologically
http://www.oie.int/for-the-media/press-releases/detail/article/oie-
scientists-review-knowledge-on-schmallenberg-virus/
World Animal Health Organisation (OIE). Includes link to ‘Technical Factsheet’ on SBV
http://www.promedmail.org/?p=2400:1000: Internet-based reporting system of the International Society for Infectious Diseases
dedicated to the rapid dissemination of information on outbreaks of infectious diseases
occurring worldwide
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genetic identiﬁcation of SBV, its culture in the laboratory, and
the experimental infection of cattle with the virus. Blood samples
from a cow with milk drop and fever were ultrasonically disrupted
and incubated for 10 days on a mosquito cell line (KC cells), before
being passaged onto a baby hamster kidney cell line (BHK21).
Cytopathic effects were visible after 5 days of incubation and viral
RNA was detected in the supernatant by qRT-PCR. Reproduction ofFig. 1. (a) To facilitate the identiﬁcation of potential cases of Schmallenberg virus infec
features for fetuses and neonates. (b) Photograph of a lamb exhibiting kyphosis.the acute disease in cattle was demonstrated by IV and/or SC inoc-
ulation of the isolated virus into three 9-month old calves. Viral ge-
netic material was detected in the blood of all three animals
between days 2 and 5 post infection: one calf developed fever on
day 4 post infection and a further animal developed diarrhoea.
All animals had seroconverted to the virus by 3 weeks post infec-
tion. This study went some way towards satisfying Koch’s postu-
lates as to SBV being the causative agent of the disease, althoughtion, the European Food Safety Authority (EFSA) produced this checklist of clinical
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tal infection during pregnancy has yet to be conﬁrmed.
In order to facilitate identiﬁcation of potential cases of SBV
infection, the European Food Safety Authority (EFSA) has issued a
‘case deﬁnition’ for fetuses and neonates as evidence of AHS
(Fig. 1).Structure of Schmallenberg virus
Electron microscopy conﬁrms that the morphology of SBV is
typical of the Bunyaviridae (Table 1). These viruses are approxi-
mately 100 nm in diameter, with surface glycoproteins projecting
from an outer envelope. The genetic structure of the virus is also
typical for Bunyaviridae, containing three segments of single-
stranded negative-sense RNA, called the large (L; 6865 nucleo-
tides), medium (M; 4415 nucleotides) and small (S; 830 nucleo-
tides) segments (Fig. 2; Hoffmann et al., 2012). On the basis of
phylogenetic analysis of the S segment (Fig. 3a), SBV is most like
Shamonda virus (Hoffmann et al., 2012).
The segmented genome of Bunyaviridae creates a potential for
re-assortment, which can lead to rapid genetic change in the virus
population. This is the process by which new subtypes of inﬂuenza
A viruses may emerge through the exchange of gene segments, in a
host simultaneously infected with viruses of more than one sub-
type, and is the major mechanism underlying the generation of
new pandemic inﬂuenza viruses. Indeed, several examples of re-
assortment in orthobunyaviruses have been reported (Yanase
et al., 2010; Aguilar et al., 2011; Blitvich et al., 2012). There has
been some suggestion that SBV is a ‘re-assortant’ (Fig. 3b and c;
Hoffmann et al., 2012). Recent work re-sequencing Japanese iso-
lates of Sathuperi and Shamonda virus and the Douglas isolate of
Sathuperi virus from Australia support this idea, with the S and L
segments of SBV most closely related to Shamonda virus isolates
and the M segment most similar to that of Sathuperi virus, respec-
tively (Yanase et al., 2012).What can we infer from our knowledge of similar viruses?
Host range
Viruses of the genus Orthobunyavirus are divided into 18 sero-
groups (International Committee on Taxonomy of Viruses, 2011),
of which the Simbu serogroup is one of the largest. Most of these
viruses have not been well characterised. Some are associated with
cattle and transmitted by biting midges (Culicoides spp.), though
this may merely reﬂect bias in the sentinel monitoring pro-
grammes that have detected these viruses. Shamonda virus wasFig. 2. Schematic diagram illustrating a Schmallenberg virus particle with glyco-
proteins (Gn and Gc) projecting from the lipid bilayer as heterodimers and the three
segments of RNA (small, S; medium, M; and large, L) in circular form in association
with nucleoprotein and the ‘L’ polymerase protein.initially identiﬁed in Nigeria in the 1960s, and was subsequently
identiﬁed in Japan in 2002, indicating that this virus probably
has an extensive geographic range (Causey et al., 1972; Yanase
et al., 2005).
Viruses from these serogroups have also been found in other
ruminants, pigs and horses (Kessell et al., 2011) with a recent re-
port of Shuni virus in horses with encephalitis (van Eeden et al.,
2012) and reports of Akabane virus in horses (Yang et al., 2008),
pigs (Huang et al., 2003) and adult cattle (Lee et al., 2002; Kono
et al., 2008) with neurological disease.
While none of the Simbu serocomplex of viruses has been dem-
onstrated to cause disease in humans, the wider Simbu serogroup
includes Oropouche and Iquito viruses, which cause a severe feb-
rile syndrome in humans in South America (Aguilar et al., 2011).
As the most closely related viruses do not cause disease in humans,
most authorities have concluded that the likelihood of SBV being
zoonotic is minimal, though the potential for rare infections cannot
be ruled out.
The Robert Koch Institute in Germany issued a questionnaire to
sheep farmers in North Rhine Westphalia which raised no suspi-
cion of human disease as a result of SBV and all farmers were sero-
negative for antibodies against SBV as monitored by an
immunoﬂuorescence antibody test (IFAT) or virus neutralisation
(VN) assay. Furthermore, no viral RNA was detected when sera
from these farmers were tested using qRT-PCR. A similar serologi-
cal survey of 301 farmers and veterinarians with known exposure
to SBV-affected herds in The Netherlands, using a VN assay, also
found no antibodies against SBV (European Centre for Disease Pre-
vention and Control, 2012), leading The European Centre for Dis-
ease Prevention and Control to declare the zoonotic risk of SBV
as ‘very unlikely’.
Pathogenesis of viral infection
Although a full description of the pathogenesis of Akabane virus
infection is likely to be provided in a forthcoming review of the
Simbu viruses (P.D. Kirkland and D.S. Finlaison, unpublished data),
several points of interest in comparison with SBV are highlighted
here. Clinical studies have identiﬁed a pattern of malformations
in Akabane outbreaks in cattle which suggest that the lesions in fe-
tuses are dependent on the developmental stage of the fetus at the
time of infection. Fetuses aborted at around 4–6 months of gesta-
tion are often the ﬁrst indication of an outbreak, followed by dead,
full-term fetuses with severe arthrogryposis (infected between 103
and 174 days of gestation), then live-born animals with less severe
arthrogryposis but with neurological deﬁcits due to hydranen-
cephaly (infected between 79 and 104 days of gestation) (Kirkland
et al., 1988).
Histopathological lesions also vary depending on the age of fe-
tus when infected. Calves infected late in gestation are born at the
start of an outbreak and may have non-suppurative encephalomy-
elitis accompanying their neurological deﬁcits. Calves born
mid-outbreak show varying degrees of neurological deﬁcits and
arthrogryposis with encephalitis, and Wallerian-type degeneration
of the spinal cord with degeneration and loss of the ventral horn
neurones and spinal nerves. Calves born towards the end of
outbreaks (i.e. those infected in early gestation) tend to display
hydranencephaly, with or without arthrogryposis, and very few
other lesions, with occasional calves exhibiting spinal cord hypo-
plasia (Hartley et al., 1977).
The incidence of lesions in affected herds can be very high with
up to 50% of calves and 80% of lambs malformed, respectively
(Kirkland, 2002). In addition, recent outbreaks in Japan and Korea
have demonstrated that some strains of Akabane virus cause
encephalitis in adult cattle (Kamata et al., 2009; Oem et al.,
2012). The disease can have considerable economic impact: an
Fig. 3. Phylogenetic trees illustrating the: (a) small; (b) medium; and (c) large segments of the Simbu serogroup viruses along with representatives from the Bunyamwera
and California serogroups. Trees were generated by maximum likelihood (DNAML) in PHYLIP. Bootstrap values > 50% (1000 replicates) are given. Scale bar indicates the
estimated number of nucleotide substitutions/site.
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1975 disease outbreak in Japan (Kono et al., 2008).
Experimental infection of pregnant sheep with Akabane virus
(Parsonson et al., 1977, 1988) suggests that a ‘time-window’ exists
during which infection results in fetal abnormalities, with abnor-
malities less frequently seen when infection occurs after day 40
of gestation. Lesions in affected ovine fetuses include hydranen-
cephaly, porencephaly, hypoplasia of the spinal cord and lungs,
arthrogryposis, brachygnathia, and scoliosis. Histopathological
changes described include skeletal muscle degeneration and oede-
ma and perivascular cufﬁng, gliosis and mineralised plaques in the
brain and spinal cord (Parsonson et al., 1981b). Due to the shorter
gestation period in sheep and goats, infected fetuses of these spe-cies do not display as distinct a pattern of malformations as de-
scribed in bovine fetuses.
In comparison to Akabane virus, initial pathology reports indi-
cated that SBV typically caused hydranencephaly, porencephaly,
hydrocephalus, cerebellar hypoplasia and micromyelia (shortening
of the spinal cord). Micromyelia particularly affected the ventral
horn of the spinal cord in calves. Histologically, affected animals
displayed a lymphohistiocytic meningo-encephalomyelitis with
glial nodules in lambs and goats and neuronal degeneration and
necrosis in the brain-stem of calves. Additional lesions included
arthrogryposis, vertebral malformations and brachygnathia infe-
rior, with myoﬁbrillar hypoplasia of skeletal muscle in both calves
and lambs (Herder et al., 2012). Other pathological features in full-
Fig. 3. continued
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2012), and non-suppurative meningoencephalitis and poliomyeli-
tis with neuronophagia (Peperkamp et al., 2012). These lesions
are very similar to those of AHS in Akabane-infected animals.
The distinct timescale of occurrence of the different lesions in cat-
tle has not been reported in the current SBV outbreak, but this may
be because of the low numbers of affected cattle to date, and pos-
sibly, the protracted period of transmission.
One critical difference between the SBV outbreak and historical
Akabane virus outbreaks is that a large number of affected full-
term fetuses contain ‘PCR detectable’ SBV RNA (Bilk et al., 2012;
van den Brom et al., 2012). However, the sensitive qRT-PCR based
methods of detection were not available when much of the histor-
ical work on Akabane virus was performed, and there have been
few reports of the isolation of this virus from full-term lambs
and calves (Levin et al., 2008). However, Akabane virus was suc-
cessfully isolated from a variety of tissues from ovine fetuses at
an earlier stage of gestation (up to 70 days) as well as from placent-
omes and chorioallantoic membranes up to 100 days of gestation
(Parsonson et al., 1981a) in the face of virus neutralising antibody
in both dam and fetus. These ﬁndings are consistent with reports
that SBV RNA can be detected in a variety of tissues from affected
lambs and calves, particularly the cerebrum, spinal cord, external
placental ﬂuid and umbilical cord (Bilk et al., 2012).
Epidemiology of virus infection
The epidemiology of Akabane and Aino viruses has been best
described following outbreaks in Australia and Japan. In Australia,
Akabane is known to be present in the northern (tropical and sub-
tropical) areas of the country, limited by the range of the primary
vector, Culicoides brevitarsis (Bishop et al., 2000). In these regions,
virus circulates annually, most animals become infected pre-pub-
erty and develop immunity which is thought to be long-lasting.
In these endemic zones, fetal malformations are rare. Virus trans-
mission in endemic zones is heavily dependent on midge abun-
dance, with transmission beginning in summer and reaching a
peak in autumn. There is also usually a lag phase between the ini-tial detection of the vector and the circulation of the virus. The on-
set of frosts typically ends viral transmission.
Large-scale outbreaks occur where unusual climatic conditions
substantially alter the host vector range, either carrying the virus
to new areas populated by naive hosts or back into previously af-
fected areas populated by young, naïve and older, previously ex-
posed hosts (Kirkland, 2002). These situations result in large
numbers of naïve animals becoming exposed and attendant
large-scale outbreaks of fetal malformation. It is worth noting that
this can occur over a large geographical area: outbreaks were re-
ported in Northern Victoria, almost 1000 km from the recognised
endemic zone (Della-Porta et al., 1976; Bishop et al., 2000), with
seroconversion rates as high as 80–100% (Della-Porta et al.,
1976). Infection returning to a previously endemic area results in
a typical pattern of malformation in the offspring of young cows
and heifers, while older animals with pre-existing immunity give
birth to unaffected calves (Kirkland, 2002).
The situation in Japan and Korea is slightly different as the Aka-
bane virus does not appear to be endemic in these temperate cli-
mates. In Japan, the virus is typically detected in the south of the
country in spring and summer before spreading northward. It is
thought that the virus is probably endemic in China and that out-
breaks in Japan are due to wind-borne spread of the main vector
Culicoides oxystoma (Yanase et al., 2010).Issues requiring research
Origins and transmission
It is unclear where SBV originated. One theory is that it may
have come with insects imported with an infected animal or with
‘cut ﬂowers’ from Africa. It is also possible that the virus was circu-
lating latently, perhaps in a reservoir host, and only causing dis-
ease when expansion of its vectors’ range gave rise to infection
of fully susceptible hosts. It is worth considering in this context
that Akabane outbreaks spread by Culicoides imicola have been re-
corded in Israel in 2002–2003 (Brenner et al., 2004; Stram et al.,
Fig. 4. Map of England and Wales indicating the initial spread of Schmallenberg virus. Figures represent numbers of cases reported by the UK Animal Health Veterinary
Laboratories Agency as of 26th of March 2012.
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1994). Thus Simbu serocomplex viruses have been present histor-
ically in the Mediterranean basin.
As of June 19th 2012, there had only been sporadic reports of
SBV infection in Southern European countries (one herd in Italy
and one in Spain, respectively) compared to the large numbers re-
ported in Northern Europe. This may indicate either that the virus
is spreading southwards after being introduced into Northern Eur-
ope, or that it has been an endemic, subclinical infection in South-
ern Europe for some time. Initial serological surveys in Germany,
France and The Netherlands suggest a decreasing incidence of
infection spreading out from a point near the Dutch–German bor-
der, a ﬁnding that corresponds with the initial reports of milk-drop
and fever syndrome in adult cattle (European Commission, 2012).
It is presumed, as for the other viruses in the Simbu serogroup,
that the insect vector for SBV is biting midges (Culicoides spp.),
however work to identify the actual vector species is ongoing. Data
from the Antwerp Institute of Tropical Medicine would appear to
conﬁrm this assumption (ProMED-mail, 2012b). Midges have been
trapped at several locations in Belgium as part of an ongoing blue
tongue virus (BTV) surveillance programme. Returning to stored
samples, SBV genetic material has been detected in three species
of midge (C. obsoletus, C. dewulﬁ and C. pulicaris) trapped in Sep-
tember and October of 2011. There are similar reports of SBV ge-
netic material in C. obseletus collected in September–November
2011 in Italy and in Culicoides spp. in Denmark in October 2011
(ProMED-mail, 2012c,d): both countries have only reported single
herds affected by SBV infection to date.
Although these ﬁndings do not prove these midges are the pri-
mary vectors, all three species are associated with the transmission
of BTV and, in the Belgian study, only the heads of these insects
were tested for the presence of virus in order to minimise the pos-
sibility of detecting virus ingested in a blood meal from an infected
animal (suggesting that virus is present in the midge salivary
glands). Studies are on-going to determine whether SBV replicates
in midges, i.e. to demonstrate their ‘vector capacity’. It is notewor-
thy that funding for the BTV surveillance programme carried out in
Antwerp is due to end soon and without this kind of monitoring,
the swift resolution of such critical questions in any future emerg-
ing disease outbreak will be difﬁcult.
Knowledge of the ecology of the vector species is important in
predicting the likelihood of the virus continuing to circulate. As
orthobunyaviruses do not replicate well at temperatures <15 C,
over-wintering strategies are important, particularly in temperate
countries. Survival of some of the proposed vector species indoors
during periods of low temperatures in Europe has been demon-
strated and is thought to contribute to the over-wintering of BTV(Napp et al., 2011). Lambing times in Europe vary from December
through to late April which does overlap with the ‘midge season’ in
the UK (April to October). However midge numbers are generally
low until the warmer months of June –September, so that most
pregnant sheep will have lambed before the midge numbers rise
substantially (assuming no prolonged, unseasonably warm peri-
ods), and it is unlikely that the disease would be perpetuated by
midges feeding on surviving viraemic lambs or their placental
ﬂuid.
However, calving occurs throughout the year including during
the peak vector season, providing a potential mechanism by which
the virus may persist from year to year. SBV RNA was detected in
lambs and calves born ‘at-term’ in 2012 (Bilk et al., 2012; van
den Brom et al., 2012) but, as yet, attempts to isolate infectious
virus have been unsuccessful. One recent report of a full-term calf
with polioencephalomyelitis and detectable SBV RNA and Simbu
group viral proteins (Peperkamp et al., 2012), as well as reports
of affected lambs since April 2012 (indicating infection in early
2012) (DEFRA, 2012) suggest SBV was circulating in cattle and
sheep in Europe in the spring of 2012.
The mechanism by which SBV arrived and became dissemi-
nated within the UK remains unknown. Both the pattern of farms
affected by SBV in the UK to date (Fig. 4) and the modelling of
midge ‘plumes’ using weather data from the UK Meteorological Of-
ﬁce support the theory that the virus ﬁrst arrived in southern
counties, with infected midges blown over from continental Eur-
ope by prevailing winds. The very high density of cases on individ-
ual farms infers either local spread or that a high proportion of
midges were infected. It is unknown whether SBV can be transmit-
ted via contact with infected fomites, although this seems unlikely
based on the evidence to date.
If dissemination is due to large numbers of infected vectors, this
may result in efﬁcient de novo infection of large numbers of naïve
cattle and sheep, which would be in keeping with data from out-
breaks of other Simbu virus infections (P.D. Kirkland and D.S. Finl-
aison, unpublished data). This is in marked contrast to the infection
of UK livestock with BTV, which caused infection of a smaller pro-
portion of animals.
To address the question of whether SBV had been previously
circulating in some European countries, it would be useful to com-
pare the density of cases occurring in the UK with that on mainland
Europe, and the ages of the mothers of affected lambs and calves.
There is some anecdotal evidence from Germany that younger ani-
mals are more likely to have affected fetuses than older animals
(ProMED-mail, 2012a), though initial serological surveys in The
Netherlands have not found any evidence to support this (Euro-
pean Commission, 2012).
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in the UK, samples from a single case may be submitted to conﬁrm
SBV on the farm, so there is relatively little information as to the
exact proportion of infected animals. There is also debate as to
whether it is better to encourage reporting by offering free testing
or alternatively to make the disease notiﬁable, and different ap-
proaches have been adopted in different countries across Europe
(e.g. SBV is notiﬁable in The Netherlands but not in the UK).
Current epidemiological data
The EFSA has produced a summary of the current epidemiolog-
ical data up to the 19th of March 2012 (European Food Safety
Authority, 2012). This report lists SBV cases conﬁrmed in Germany,
Holland, Belgium, France, Luxembourg, Italy, Spain and England.
Denmark was added to this list in June 2012 (ProMED-mail,
2012e). The distribution follows that of BTV-8 outbreaks in North-
ern Europe in 2006–2008. Affected animals include cattle, sheep,
goats and one bison, with the recent addition of roe deer and lla-
mas (ProMED-mail, 2012f; Jack et al., 2012), although clinical diar-
rhoea syndrome has only been conﬁrmed in eight cattle. The vast
bulk of the reported cases in the early part of the outbreak was
in sheep, partly because cattle have a much longer gestation period
and calves infected in utero at the same time as lambs are born la-
ter. Most of the cases born later in the outbreak (after April) were
in cattle.
Several countries have declared the current SBV outbreak re-
solved with the total number of affected premises in Europe as of
31st May, 2012 standing at 2062 cattle, 2482 sheep and 77 goat
farms (ProMED-mail, 2012g). Extrapolation of the estimated date
of infection of lamb fetuses from their birth date would indicate
that the virus circulated from May to November 2011 with the
peak of viral circulation occurring in October 2011. This would
indicate that virus was circulating in sheep well before the initial
disease outbreak was reported in cattle in August. These dates
are also signiﬁcant in that lambs and calves born in spring and
summer 2012 have qRT-PCR detectable viral RNA at a time when
potential vectors are becoming active.
Given that some of the midge species identiﬁed to date are
present over most of Northern Europe, this makes further viral
transmission in 2012 and the establishment of endemic infection
a real possibility. The total number of herds affected compared
with the total number of herds in the reporting countries is low
with morbidity and mortality estimates of <3% in affected coun-
tries (ProMED-mail, 2012g). However, as the EFSA report indicates,
there is likely to be serious under-reporting of cases, and few EU
countries have provided morbidity rates for individual herds.
Prevention and control
Management of outbreaks of Akabane and Aino viral disease in
Japan and Australia is largely dependent on sentinel monitoring of
vectors and cattle. In Japan, strategic deployment of vaccines is ap-
plied if it is apparent that virus is circulating (vaccines are not cur-
rently available in Australia). Suggestions have been made that
restricting the timing of mating in cattle and sheep to outside of
the vector season may be an option to reduce SBV cases in future
years (Anon, 2012). However, the distinctive seasonality of the
reproductive cycle in sheep in Europe renders this strategy eco-
nomically impractical in most instances. Although delaying the
insemination of cattle may be a management option, such a change
may be problematic, necessitating signiﬁcant changes in hus-
bandry and potentially resulting in substantial economic losses.
Recommendations for control of bunyavirus infections in hu-
mans include avoidance of mosquito exposure by staying indoors
at dusk, the peak mosquito biting period, and through the use ofmosquito nets and insecticides. Such an approach remains imprac-
tical for all but very valuable livestock. Clearly transporting naïve
animals to endemic areas for mating or during pregnancy is to be
avoided.
Discussions about the testing of animals, semen and embryos
for trading purposes are complicated by the fact that serological
tests do not indicate when an animal was infected so do not indi-
cate the likelihood that that animal will give birth to an affected fe-
tus. There has also not yet been time to assess the risk of infection
via semen, although this seems unlikely as experimental infection
of bulls with Akabane virus results in viraemia, but does not pro-
duce detectable virus in semen (Parsonson et al., 1981c). Infection
of embryos recovered from subclinically infected animals is an un-
known risk at present.
Several non-European countries have placed movement bans on
EU livestock due to the risk of SBV transfer, although the Chief Vet-
erinary Ofﬁcers within the EU have issued a joint statement indi-
cating that SBV-affected animals and regions should only be
subject to the same controls that apply to other viruses of the Sim-
bu group (European Commission, 2012). The widespread nature of
the potential vector species for SBV within Europe and the speed
and range over which Simbu viruses can spread probably renders
vector control, or the placement of movement restrictions on ani-
mals, relatively futile. From a pragmatic perspective, until a vac-
cine becomes available there is little that can currently be done
to reduce the impact of SBV.
Diagnostic assays
The qRT-PCR developed by the FLI is the primary diagnostic as-
say used by laboratories in affected countries, and it is currently
recommended that brain, blood, spleen and placental samples
are tested. This assay does have limitations in detecting infected
individuals based on blood samples, as it only detects viral RNA
when the animal is viraemic. The report by van den Brom et al.
(2012) indicated that only 40.7% of lambs with typical malforma-
tions from known affected ﬂocks tested positive for viral RNA in
brain tissue. A high proportion of calves have SBV antibodies ‘at
term’ and serum or pericardial ﬂuid may be used for the detection
of antibodies by ELISA or VNT (P.D. Kirkland, personal communica-
tion). Serology is a reliable method of detecting Akabane virus
infection in non-endemic areas in the dams of affected calves,
and this approach is beginning to be used in Europe to detect
SBV (Jack et al., 2012). There is currently a critical need for serolog-
ical testing of adult animals to establish what proportion of na-
tional ﬂocks and herds remain susceptible should SBV continue
to circulate.
Use of a VN assay in The Netherlands indicates that 70% of the
dairy cattle in the country have seroconverted with a higher prev-
alence in the east of the country and a within-ﬂock/herd seropre-
valences of 70–95% (sheep) and 70–100% (dairy cattle),
respectively. Initial results using an IFAT test in Germany indicate
that there is a higher prevalence in the north-west than in the
south-east of the country. Initial VN assays in some French herds
indicate 32–100% seropositivity in affected herds in the north of
the country, compared with only 7.5% on an affected farm in the
central region (European Commission, 2012). Ongoing research is
focused on developing SBV-speciﬁc serological tests for high-
throughput screening, with the ﬁrst commercial ELISA made avail-
able by French company IDvet.
Vaccine development
Research is also directed at developing a SBV vaccine. Numer-
ous vaccination strategies have been deployed against zoonotic
bunyaviruses such as Rift Valley fever virus (Ikegami and Makino,
R. Tarlinton et al. / The Veterinary Journal 194 (2012) 10–18 172009), and a number of these have been proposed in the context of
developing a SBV vaccine. Regulatory approval is more likely to be
obtained for a non-replicating vaccine, as one of the major risks of
a live virus vaccine is the potential teratogenic effects in livestock
accidentally inoculated while pregnant.
Several Akabane vaccines have been deployed in Australia and
Japan. Inoculation with formalin-inactivated aluminium phos-
phate-adjuvanted viral preparations resulted in the production of
VN antibody in animals following two doses given 4 weeks apart
(Kurogi et al., 1978). In Japan, live attenuated and killed adjuvanted
vaccines against Akabane virus are currently registered for use in
cattle. To date, there are no reported trials assessing if there is cross
protection by these vaccines against SBV infection. Furthermore,
the situation pertaining with SBV is quite different to that of the re-
cent BTV-8 outbreak in Europe, where rapid deployment of a
monovalent inactivated vaccine was facilitated by the availability
of existing efﬁcacy and safety data for this vaccine from countries
where BTV-8 is endemic.Conclusions
The outcome of the emergence of SBV in Europe remains hard to
predict. However, with the UK being the largest producer of sheep
meat in Europe, and the ﬁfth largest producer worldwide, there is
the potential for a considerable economic impact on farmers, the
meat industry and food supply, both in the UK and on mainland
Europe. Yet there remains reason for optimism. The experience
gleaned from the study of closely related viruses may result in
more rapid progress towards the control of SBV infection, and it
is clear that through the expeditious research of many groups,
the next 12 months will provide a further wealth of information
about this previously unknown disease. Forging and strengthening
international collaborations will enable existing expertise on re-
lated viruses to be used constructively and decisions about how
to proceed to be evidence-based.
At the time of its initial isolation, it was not clear if SBV was a
coincidental ﬁnding or the cause of this novel disease. The early
sharing of information about the virus by the FLI via a press release
on 21st November 2011 proved vital to the rapid identiﬁcation of
the ﬁrst malformed lambs and calves in the spring of 2012. The
FLI also facilitated the rapid establishment of a diagnostic capabil-
ity in the veterinary laboratories of other EU states by making the
details of their qRT-PCR test available. On occasions in the past,
researchers have delayed announcing new ﬁndings until they
had sufﬁcient data for submission to a high impact journal. The
timely release of information regarding SBV has not only facilitated
its rapid diagnosis but has also promoted healthy competition to
develop new diagnostic assays and vaccines. This provides an
exemplar of a coordinated international response to future emer-
gent disease threats.
Unfortunately, given factors such as climate change and in-
creased globalisation, SBV is unlikely to be the last ‘exotic’ vec-
tor-borne disease to affect European livestock. However, the
experience of this outbreak of SBV infection should assist in the
development of systems that facilitate the rapid identiﬁcation
and notiﬁcation of emerging diseases and streamline government
responses in areas such as disease control and reactive research
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